Formula Growth’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Sell
221,347
-17,861
-7% -$343K 1.85% 5
2026
Q1
$4.21M Sell
239,208
-300
-0.1% -$6.03K 1.9% 7
2025
Q4
$4.73M Sell
239,508
-8,700
-4% -$156K 1.82% 10
2025
Q3
$4.33M Buy
248,208
+67,000
+37% +$993K 1.54% 17
2025
Q2
$2.54M Buy
181,208
+51,208
+39% +$825K 0.96% 40
2025
Q1
$2.42M Buy
+130,000
New +$1.94M 0.98% 42
2023
Q1
Sell
-190,400
Closed -$2.24M 130
2022
Q4
$2.24M Buy
+190,400
New +$2.32M 0.63% 63

Other funds holding ALHC

Formula Growth's ALHC Position: Q2 2026 in Review

Formula Growth reduced its Alignment Healthcare (ALHC) stake by 7.5% in Q2 2026, selling an estimated $343K and leaving 221,347 shares worth $5.27M. The position accounts for 1.85% of the portfolio, ranked #5.

Formula Growth first reported a position in ALHC in Q4 2022 and has held it in 7 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Formula Growth held 221,347 shares of Alignment Healthcare worth $5.27M as of Q2 2026.
  • Formula Growth sold 17,861 Alignment Healthcare shares in Q2 2026, an estimated $343K.
  • Alignment Healthcare made up 1.85% of Formula Growth's portfolio in Q2 2026, its #5 holding.
  • Formula Growth first reported a position in Alignment Healthcare in Q4 2022 and has held it in 7 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.